Alia Therapeutics
Safe and durable gene editing solutions for patients
Trento, Italy · Founded 2018
- Headquarters
- Trento
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- aliatherapeutics.com
About
Alia Therapeutics is a biotechnology company dedicated to developing next-generation gene editing therapies for Inherited Retinal Diseases, starting with Retinitis Pigmentosa, a leading cause of inherited blindness worldwide. The company leverages a proprietary CRISPR platform featuring novel, next-generation enzymes discovered in-house that enable a modular, mutation-agnostic approach using a single AAV vector. Founded in 2018 out of pioneering research at Trento University, Alia aims to transform treatment of inherited blindness by delivering scalable, precise, and durable gene editing solutions.
Summary
Alia Therapeutics is a Biotech company based in Trento, Italy, founded in 2018.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...